tm
Seeing Is Believing
tm
Seeing Is Believing
ANIP is currently covered by 5 analysts with an average price target of $104.35. This is a potential upside of $19.47 (22.94%) from yesterday's end of day stock price of $84.88.
ANI Pharmaceuticals's activity chart (see below) currently has 65 price targets and 65 ratings on display. The stock rating distribution of ANIP is 91.67% BUY and 8.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 76.62% with an average time for these price targets to be met of 338.13 days.
Highest price target for ANIP is $94, Lowest price target is $62, average price target is $81.8.
Most recent stock forecast was given by BRANDON FOLKES from CANTOR FITZGERALD on 10-Jul-2025. First documented stock forecast 15-Dec-2014.
Currently out of the existing stock ratings of ANIP, 22 are a BUY (91.67%), 2 are a HOLD (8.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$84
$14.99 (21.72%)
$42
1 months 1 days ago
(10-Jul-2025)
2/4 (50%)
$17.9 (27.08%)
274
Buy
$86
$16.99 (24.62%)
$86
2 months 30 days ago
(12-May-2025)
6/10 (60%)
$23.7 (38.04%)
343
Buy
$94
$24.99 (36.21%)
$94
4 months 25 days ago
(17-Mar-2025)
4/13 (30.77%)
$29.65 (46.08%)
148
Hold
$62
$-7.01 (-10.16%)
$60
9 months 20 days ago
(22-Oct-2024)
8/9 (88.89%)
$1.92 (3.20%)
396
Buy
$83
$13.99 (20.27%)
$49
10 months 24 days ago
(18-Sep-2024)
10/12 (83.33%)
$21.95 (35.95%)
474
What is ANIP (ANI Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ANIP (ANI Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ANIP (ANI Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ANIP (ANI Pharmaceuticals)?
Which analyst is the currently most bullish on ANIP (ANI Pharmaceuticals)?
Which analyst is the currently most reserved on ANIP (ANI Pharmaceuticals)?
